The ACES Study for Aseptic Pleural Effusion
Launched by PLEURAL DYNAMICS, INC. · Jan 8, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The ACES Study is looking at a treatment for patients who have a condition called recurrent aseptic pleural effusion, which is when fluid builds up in the space around the lungs without an infection. This study aims to see how well a device called a catheter can help control this fluid. To join the study, participants need to have had previous fluid removal procedures and show symptoms like shortness of breath or chest discomfort. They should also be able to follow the study's requirements, which include attending follow-up visits.
If someone is eligible and agrees to participate, they will have some initial tests, including a physical exam and imaging of the chest, to assess their condition. After the catheter is placed, they will stay in the hospital for observation before going home. Participants will also be given electronic diaries to help track any pain and difficulty breathing they experience at home. This study is currently recruiting patients of all genders, aged 16 and older.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Recurrent pleural effusion after thoracentesis for which the physician has determined that a catheter implantation is indicated.
- • 2. Symptoms of PE such as shortness of breath, cough, or chest fullness/chest discomfort based on patient report to physician.
- • 3. Eastern Cooperative Oncology Group (ECOG) performance status of 0-3.
- • 4. Patient is willing and able to meet all study requirements, including follow-up visits and receiving study related telephone calls.
- Exclusion Criteria:
- • 1. Recurrent pleural effusion after thoracentesis for which the physician has determined that a catheter implantation is indicated.
- • 2. Symptoms of PE such as shortness of breath, cough, or chest fullness/chest discomfort based on patient report to physician.
- • 3. Eastern Cooperative Oncology Group (ECOG) performance status of 0-3.
- • 4. Patient is willing and able to meet all study requirements, including follow-up visits and receiving study related telephone calls.
About Pleural Dynamics, Inc.
Pleural Dynamics, Inc. is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative solutions for pleural disease management. Focused on developing cutting-edge medical devices and therapies, the company aims to improve patient outcomes and enhance the quality of care in thoracic medicine. With a commitment to rigorous clinical research and collaboration with healthcare professionals, Pleural Dynamics, Inc. strives to bring transformative technologies to the market, ensuring safety and efficacy for patients suffering from pleural conditions. Their expertise in clinical development and dedication to scientific excellence position them as a leader in the field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Hollywood, Florida, United States
Baltimore, Maryland, United States
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Fabien Moldanado, MD, MSc
Principal Investigator
Vanderbilt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported